← All stocks

Labcorp

LH Net selling
CIK 0000920148 #284 in the set updated 17 Sep 2026
Bought (120 mo)
$1.04M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$175.44M
$18.90M on a plan · $105.33M straight out of an exercise
Sold at will
$51.21M
114 of 210 sales
Net
−$174.40M
−$50.17M against sales at will

By person

36 insiders · 219 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
KING DAVID P
Director
$63.14M (15) scheduled
−$63.14M
344,155
0.4244%
$109.45M
+77.8%
EISENBERG GLENN A
Executive Vice President
$34.20M (27) scheduled
−$34.20M
37,920
0.0468%
$12.06M
+358.6%
Schechter Adam H
President & CEO
$14.69M (10) scheduled
−$14.69M
102,565
0.1265%
$32.62M
+2,192%
van der Vaart Sandra D
EVP, Corporate Affairs
$8.53M (33) scheduled
−$8.53M
6,239
0.0077%
$1.98M
+368.6%
ANDERSON KERRII B
Director
$7.56M (19) scheduled
−$7.56M
6,563
0.0081%
$2.09M
−62.5%
Schroeder Mark S
EVP, Pres Diagnostics & COO
$7.42M (22) scheduled
−$7.42M
12,677
0.0156%
$4.03M
+1,951%
BELINGARD JEAN-LUC
Director
$6.41M (4) scheduled
−$6.41M
17,781
0.0219%
$5.65M
−41.8%
BERBERIAN LANCE
EVP, Special Advisor, Strategy
$5.28M (6)
−$5.28M
18,652
0.0230%
$5.93M
+1,436%
EBERTS F SAMUEL III
Chief Legal Officer, Secretary
$4.89M (1) scheduled
−$4.89M
28,823
0.0355%
$9.17M
+59.5%
Kirchgraber Paul R
CEO, Covance Drug Development
$3.95M (4) scheduled
−$3.95M
12,946
0.0160%
$4.12M
+193.8%
Wilkinson Peter J
SVP, Chief Accounting Officer
$3.73M (15) scheduled
−$3.73M
1,770
0.0022%
$562.97K
+1,270%
Dodson Edward T
Principal Accounting Officer
$2.84M (3) scheduled
−$2.84M
13,663
0.0168%
$4.35M
+311.3%
Uthgenannt Lisa J
Chief Human Resources Officer
$2.69M (4)
−$2.69M
4,660
0.0057%
$1.48M
+23.3%
Summy Amy B.
EVP, Chief Marketing Officer
$2.27M (7) scheduled
−$2.27M
6,956
0.0086%
$2.21M
Parham Richelle P
Director
$1.78M (1)
−$1.78M
3,366
0.0042%
$1.07M
Williams R Sanders
Director
$1.47M (11)
−$1.47M
8,120
0.0100%
$2.58M
+50.0%
MITTELSTAEDT ROBERT E JR
Director
$1.37M (6) scheduled
−$1.37M
15,515
0.0191%
$4.93M
+36.7%
Gilliland Dwight Gary
Director
$1.30M (11)
−$1.30M
6,656
0.0082%
$2.12M
+128.6%
NEUPERT PETER M
Director
$922.82K (3)
+$922.82K
13,784
0.0170%
$4.38M
Caveney Brian J
EVP, Pres of BLS, CMO & CSO
$20.42K (2)
$923.46K (2)
−$903.03K
36,492
0.0450%
$11.61M
+3,767%
Meltzer Jonathan C
EVP, COO
$298.76K (4) scheduled
−$298.76K
3,620
0.0045%
$1.15M
+43.8%
Gary M. Huff
CEO, LabCorp Diagnostics
$293.82K (1)
−$293.82K
1,850
0.0023%
$588.21K
+359.4%
Kyle Kathryn W
EVP, Chief Legal Officer
$227.41K (2) scheduled
−$227.41K
3,904
0.0048%
$1.24M
+27.9%
DiVincenzo Jonathan P.
EVP, Pres, Central Labs & Intl
$107.75K (1)
−$107.75K
5,461
0.0067%
$1.74M
+65.0%
Seltz Judith C
EVP, CHRO
$99.36K (2)
+$99.36K
4,182
0.0052%
$1.33M
+1,075%
Vaughn Bryan T
EVP and President, Diagnostics
$66.97K (1) scheduled
−$66.97K
6,746
0.0083%
$2.15M
+31.1%
Ratliff John D
CEO, Covance Drug Development
16,941
0.0209%
$5.39M
Kong Garheng
Director
13,739
0.0169%
$4.37M
+308.4%
Davis Jeffrey A.
Director
5,460
0.0067%
$1.74M
GRAHAM ANITA Z
EVP, CHRO
5,185
0.0064%
$1.65M
+17,183%
Oyegunwa Akinbolade
EVP, CIO & CTO
5,064
0.0062%
$1.61M
+89.9%
Bailey Megan D.
EVP, Pres, Central Labs & Intl
4,851
0.0060%
$1.54M
+3,876%
Wengel Kathryn E
Director
4,133
0.0051%
$1.31M
Kliphouse Kirsten Marie
Director
3,160
0.0039%
$1.00M
Rothman Paul
Director
2,571
0.0032%
$817.63K
+19,677%
Wang Julia Aijun
Chief Financial Officer, EVP
1,817
0.0022%
$577.92K
+29,027%
Insider
Date
Role
Action
Shares
Price
Amount
ANDERSON KERRII B
17 Aug 2026
Director
Sold on a plan
3,000
$318.02
$954.06K
Schechter Adam H
11 Aug 2026
President & CEO
Sold on a plan
4,669
$320.37
$1.50M
Summy Amy B.
4 Aug 2026
EVP, Chief Marketing Officer
Sell
924
$306.74
$283.43K
Wilkinson Peter J
3 Aug 2026
SVP, Chief Accounting Officer
Sold after exercise
1,338
$309.23
$413.75K
Wilkinson Peter J
3 Aug 2026
SVP, Chief Accounting Officer
Sold after exercise
82
$309.22
$25.36K
Vaughn Bryan T
2 Jul 2026
EVP and President, Diagnostics
Sold on a plan
234
$286.19
$66.97K
Kyle Kathryn W
2 Jul 2026
EVP, Chief Legal Officer
Sold on a plan
92
$286.19
$26.33K
Kyle Kathryn W
8 Jun 2026
EVP, Chief Legal Officer
Sold on a plan
762
$263.89
$201.08K
Schechter Adam H
11 May 2026
President & CEO
Sold on a plan
5,903
$254.50
$1.50M
Meltzer Jonathan C
27 Mar 2026
EVP, Operations
Sold on a plan
839
$267.05
$224.05K
Wilkinson Peter J
27 Mar 2026
SVP, Chief Accounting Officer
Sold on a plan
1,633
$267.05
$436.09K
Schechter Adam H
3 Mar 2026
President & CEO
Sell
8,705
$279.96
$2.44M
van der Vaart Sandra D
27 Feb 2026
EVP, Corporate Affairs
Sell
548
$284.91
$156.00K
Caveney Brian J
24 Feb 2026
EVP, Pres of ED, CMO & CSO
Sell
1,500
$286.31
$429.46K
Wilkinson Peter J
19 Feb 2026
SVP, Chief Accounting Officer
Sold on a plan
666
$277.94
$185.11K
Meltzer Jonathan C
12 Feb 2026
EVP, Operations
Sold on a plan
87
$290.42
$25.27K
Schechter Adam H
11 Feb 2026
President & CEO
Sold after exercise
5,273
$284.38
$1.50M
Meltzer Jonathan C
10 Feb 2026
EVP, Operations
Sold on a plan
91
$276.79
$25.19K
Meltzer Jonathan C
9 Feb 2026
EVP, Operations
Sold on a plan
88
$275.53
$24.25K
Schechter Adam H
11 Nov 2025
President & CEO
Sold on a plan
5,745
$262.75
$1.51M
Parham Richelle P
31 Oct 2025
Director
Sell
7,009
$254.28
$1.78M
van der Vaart Sandra D
13 Aug 2025
EVP, Chief Legal Officer
Sold after exercise
3,903
$271.42
$1.06M
Schechter Adam H
11 Aug 2025
President & CEO
Sold on a plan
5,643
$266.78
$1.51M
Gilliland Dwight Gary
30 Jul 2025
Director
Sell
2,000
$264.95
$529.90K
Wilkinson Peter J
29 Jul 2025
SVP, Chief Accounting Officer
Sell
100
$261.04
$26.10K
Wilkinson Peter J
29 Jul 2025
SVP, Chief Accounting Officer
Sell
102
$261.01
$26.62K
ANDERSON KERRII B
24 Jul 2025
Director
Sold on a plan
3,500
$280.00
$980.00K
ANDERSON KERRII B
24 Jul 2025
Director
Sold on a plan
3,500
$280.00
$980.00K
ANDERSON KERRII B
1 Jul 2025
Director
Sold on a plan
500
$265.00
$132.50K
ANDERSON KERRII B
11 Jun 2025
Director
Sell
500
$260.00
$130.00K
Caveney Brian J
3 Jun 2025
EVP, Pres of ED, CMO & CSO
Sell
2,000
$247.00
$494.00K
Schechter Adam H
12 May 2025
President & CEO
Sold on a plan
6,105
$248.73
$1.52M
Wilkinson Peter J
1 May 2025
SVP, Chief Accounting Officer
Sell
829
$242.27
$200.84K
van der Vaart Sandra D
1 May 2025
EVP, Chief Legal Officer
Sell
1,900
$238.36
$452.88K
Schroeder Mark S
28 Mar 2025
EVP, Pres Diagnostics & COO
Sold on a plan
2,635
$231.67
$610.45K
Summy Amy B.
28 Mar 2025
EVP, Chief Marketing Officer
Sold on a plan
758
$231.67
$175.61K
ANDERSON KERRII B
5 Mar 2025
Director
Sell
500
$255.63
$127.82K
Schroeder Mark S
28 Feb 2025
EVP, Pres Diagnostics & COO
Sold after exercise
5,339
$249.23
$1.33M
van der Vaart Sandra D
25 Feb 2025
EVP, Chief Legal Officer
Sell
1,314
$251.30
$330.21K
Summy Amy B.
24 Feb 2025
EVP, Chief Marketing Officer
Sold on a plan
226
$250.40
$56.59K
Wilkinson Peter J
18 Feb 2025
SVP, Chief Accounting Officer
Sold after exercise
1,413
$246.10
$347.74K
Schechter Adam H
11 Feb 2025
President & CEO
Sold after exercise
6,121
$244.62
$1.50M
ANDERSON KERRII B
7 Jan 2025
Director
Sold on a plan
1,000
$235.00
$235.00K
Gilliland Dwight Gary
2 Dec 2024
Director
Sell
1,000
$241.00
$241.00K
EISENBERG GLENN A
2 Dec 2024
Executive Vice President
Sold after exercise
11,711
$240.43
$2.82M
Summy Amy B.
22 Nov 2024
EVP, Chief Marketing Officer
Sold after exercise
3,672
$238.91
$877.14K
van der Vaart Sandra D
21 Nov 2024
EVP, Chief Legal Officer
Sell
1,000
$239.42
$239.42K
Schechter Adam H
11 Nov 2024
President & CEO
Sold on a plan
6,189
$243.47
$1.51M
ANDERSON KERRII B
24 Oct 2024
Director
Sold on a plan
1,000
$230.00
$230.00K
van der Vaart Sandra D
19 Aug 2024
EVP, Chief Legal Officer
Sell
2,000
$227.05
$454.10K
EISENBERG GLENN A
15 Aug 2024
Chief Financial Officer, EVP
Sell
9,071
$224.55
$2.04M
EISENBERG GLENN A
15 Aug 2024
Chief Financial Officer, EVP
Sell
2,950
$223.62
$659.67K
EISENBERG GLENN A
15 Aug 2024
Chief Financial Officer, EVP
Sell
2,979
$222.65
$663.27K
ANDERSON KERRII B
8 Aug 2024
Director
Sold on a plan
586
$225.00
$131.85K
ANDERSON KERRII B
7 Aug 2024
Director
Sold on a plan
414
$225.00
$93.15K
BERBERIAN LANCE
5 Aug 2024
EVP, CIO & CTO
Sell
9,848
$228.95
$2.25M
BERBERIAN LANCE
5 Aug 2024
EVP, CIO & CTO
Sell
2,245
$229.79
$515.87K
van der Vaart Sandra D
14 May 2024
EVP, Chief Legal Officer
Sell
200
$210.84
$42.17K
van der Vaart Sandra D
14 May 2024
EVP, Chief Legal Officer
Sell
1,800
$210.83
$379.49K
ANDERSON KERRII B
2 May 2024
Director
Sell
250
$200.10
$50.02K
ANDERSON KERRII B
30 Apr 2024
Director
Sell
250
$204.14
$51.03K
Wilkinson Peter J
29 Apr 2024
SVP, Chief Accounting Officer
Sell
2,439
$204.33
$498.36K
Summy Amy B.
1 Apr 2024
EVP, Chief Marketing Officer
Sold on a plan
3,500
$217.29
$760.52K
Schroeder Mark S
1 Apr 2024
EVP, Pres Diagnostics & COO
Sold on a plan
6,477
$217.29
$1.41M
van der Vaart Sandra D
28 Mar 2024
EVP, Chief Legal Officer
Sold on a plan
3,553
$216.74
$770.08K
Summy Amy B.
7 Mar 2024
EVP, Chief Marketing Officer
Sold on a plan
227
$218.45
$49.59K
Schroeder Mark S
7 Mar 2024
EVP, Pres Diagnostics & COO
Sold after exercise
5,048
$218.45
$1.10M
DiVincenzo Jonathan P.
21 Feb 2024
EVP, Pres, Central Labs & Intl
Sell
500
$215.49
$107.75K
EISENBERG GLENN A
21 Feb 2024
Chief Financial Officer, EVP
Sold after exercise
1,553
$217.98
$338.53K
EISENBERG GLENN A
21 Feb 2024
Chief Financial Officer, EVP
Sold after exercise
6,665
$217.52
$1.45M
EISENBERG GLENN A
21 Feb 2024
Chief Financial Officer, EVP
Sold after exercise
7,907
$215.68
$1.71M
EISENBERG GLENN A
21 Feb 2024
Chief Financial Officer, EVP
Sold after exercise
18,379
$215.37
$3.96M
van der Vaart Sandra D
13 Feb 2024
EVP, Chief Legal Officer
Sold on a plan
237
$226.45
$53.67K
van der Vaart Sandra D
8 Feb 2024
EVP, Chief Legal Officer
Sold on a plan
259
$222.06
$57.51K
van der Vaart Sandra D
5 Feb 2024
EVP, Chief Legal Officer
Sold on a plan
193
$220.57
$42.57K
Wilkinson Peter J
16 Nov 2023
SVP, Chief Accounting Officer
Sell
1,384
$210.71
$291.63K
ANDERSON KERRII B
8 Aug 2023
Director
Sell
5,000
$211.57
$1.06M
van der Vaart Sandra D
29 Jun 2023
EVP, Chief Legal Officer
Sold on a plan
212
$240.00
$50.88K
Kirchgraber Paul R
19 May 2023
CEO, Covance Drug Development
Sold after exercise
4,300
$216.91
$932.71K
Schroeder Mark S
18 May 2023
EVP, Pres Diagnostics & COO
Sold after exercise
1,500
$216.77
$325.16K
Schroeder Mark S
31 Mar 2023
EVP, President-Diagnostics Lab
Sold on a plan
3,897
$225.81
$879.98K
Kirchgraber Paul R
21 Feb 2023
CEO, Covance Drug Development
Sold after exercise
8,000
$250.58
$2.00M
Schroeder Mark S
14 Feb 2023
EVP, President-Diagnostics Lab
Sell
309
$247.63
$76.52K
Schroeder Mark S
7 Feb 2023
EVP, President-Diagnostics Lab
Sell
409
$243.01
$99.39K
van der Vaart Sandra D
7 Feb 2023
EVP, Chief Legal Officer
Sell
219
$243.01
$53.22K
Schroeder Mark S
3 Feb 2023
EVP, President-Diagnostics Lab
Sell
324
$253.90
$82.26K
van der Vaart Sandra D
3 Feb 2023
EVP, Chief Legal Officer
Sell
173
$253.90
$43.92K
Schroeder Mark S
8 Nov 2022
EVP, President-Diagnostics Lab
Sell
1,116
$232.67
$259.66K
EISENBERG GLENN A
26 Sep 2022
Chief Financial Officer, EVP
Sell
2,830
$211.86
$599.57K
EISENBERG GLENN A
26 Sep 2022
Chief Financial Officer, EVP
Sell
11,699
$211.13
$2.47M
EISENBERG GLENN A
26 Sep 2022
Chief Financial Officer, EVP
Sell
4,844
$210.21
$1.02M
EISENBERG GLENN A
26 Sep 2022
Chief Financial Officer, EVP
Sell
5,627
$209.29
$1.18M
Caveney Brian J
7 Sep 2022
EVP, President of Diagnostics
Buy
44
$231.20
$10.25K
EISENBERG GLENN A
3 Aug 2022
Chief Financial Officer, EVP
Sold after exercise
1,500
$254.88
$382.32K
EISENBERG GLENN A
3 Aug 2022
Chief Financial Officer, EVP
Sold after exercise
19,338
$254.26
$4.92M
EISENBERG GLENN A
3 Aug 2022
Chief Financial Officer, EVP
Sold after exercise
11,262
$253.27
$2.85M
Wilkinson Peter J
1 Aug 2022
SVP, Chief Accounting Officer
Sold after exercise
10
$258.71
$2.59K
Wilkinson Peter J
1 Aug 2022
SVP, Chief Accounting Officer
Sold after exercise
757
$258.60
$195.76K
Wilkinson Peter J
1 Aug 2022
SVP, Chief Accounting Officer
Sold after exercise
1,809
$258.31
$467.29K
Caveney Brian J
7 Jun 2022
EVP, President of Diagnostics
Buy
42
$242.19
$10.17K
van der Vaart Sandra D
29 Mar 2022
EVP, Chief Legal Officer
Sell
2,449
$277.11
$678.64K
Schroeder Mark S
29 Mar 2022
EVP, President-Diagnostics Lab
Sell
2,356
$277.11
$652.87K
Williams R Sanders
25 Mar 2022
Director
Sell
572
$272.98
$156.14K
Summy Amy B.
10 Mar 2022
EVP, Chief Marketing Officer
Sell
249
$262.21
$65.29K
NEUPERT PETER M
16 Feb 2022
Director
Buy
600
$264.57
$158.74K
NEUPERT PETER M
16 Feb 2022
Director
Buy
1,600
$263.98
$422.37K
NEUPERT PETER M
16 Feb 2022
Director
Buy
1,300
$262.85
$341.71K
van der Vaart Sandra D
15 Feb 2022
EVP, Chief Legal Officer
Sell
207
$273.98
$56.71K
Schroeder Mark S
15 Feb 2022
EVP, President-Diagnostics Lab
Sell
207
$273.98
$56.71K
van der Vaart Sandra D
7 Feb 2022
EVP, Chief Legal Officer
Sell
218
$277.38
$60.47K
Schroeder Mark S
7 Feb 2022
EVP, President-Diagnostics Lab
Sell
204
$277.38
$56.59K
van der Vaart Sandra D
3 Feb 2022
EVP, Chief Legal Officer
Sell
172
$271.81
$46.75K
Schroeder Mark S
3 Feb 2022
EVP, President-Diagnostics Lab
Sell
161
$271.81
$43.76K
Gilliland Dwight Gary
15 Dec 2021
Director
Sell
18
$302.31
$5.44K
Gilliland Dwight Gary
15 Dec 2021
Director
Sell
25
$302.28
$7.56K
Gilliland Dwight Gary
15 Dec 2021
Director
Sell
100
$302.26
$30.23K
Gilliland Dwight Gary
15 Dec 2021
Director
Sell
357
$302.25
$107.90K
van der Vaart Sandra D
15 Sep 2021
EVP, Chief Legal Officer
Sold after exercise
4,500
$296.78
$1.34M
van der Vaart Sandra D
7 Jun 2021
EVP, Chief Legal Officer
Sold after exercise
4,500
$266.56
$1.20M
Kirchgraber Paul R
6 May 2021
CEO, Covance Drug Development
Sell
2,500
$276.55
$691.38K
BELINGARD JEAN-LUC
3 May 2021
Director
Sold after exercise
2,600
$269.16
$699.80K
van der Vaart Sandra D
30 Mar 2021
EVP, Chief Legal Officer
Sell
812
$251.88
$204.53K
Schroeder Mark S
30 Mar 2021
EVP, President-Diagnostics Lab
Sell
667
$251.88
$168.00K
Wilkinson Peter J
18 Feb 2021
SVP, Chief Accounting Officer
Sold after exercise
2,317
$241.51
$559.59K
Schroeder Mark S
16 Feb 2021
EVP, President-Diagnostics Lab
Sell
85
$237.06
$20.15K
Schroeder Mark S
16 Feb 2021
EVP, President-Diagnostics Lab
Sell
103
$237.06
$24.42K
van der Vaart Sandra D
16 Feb 2021
EVP, Chief Legal Officer
Sell
100
$236.05
$23.61K
van der Vaart Sandra D
16 Feb 2021
EVP, Chief Legal Officer
Sell
5
$235.89
$1.18K
van der Vaart Sandra D
16 Feb 2021
EVP, Chief Legal Officer
Sell
103
$237.06
$24.42K
Schroeder Mark S
5 Feb 2021
EVP, President-Diagnostics Lab
Sell
203
$225.85
$45.85K
van der Vaart Sandra D
5 Feb 2021
EVP, Chief Legal Officer
Sell
109
$225.85
$24.62K
Williams R Sanders
26 Jan 2021
Director
Exercised, kept
1,300
$98.49
$128.04K
Schroeder Mark S
6 Nov 2020
EVP, President-Diagnostics Lab
Sell
588
$214.59
$126.18K
Kirchgraber Paul R
4 Nov 2020
CEO, Covance Drug Development
Sell
1,500
$214.14
$321.20K
Williams R Sanders
8 Jul 2020
Director
Sold after exercise
1,300
$173.12
$225.06K
van der Vaart Sandra D
2 Jul 2020
EVP, Chief Legal Officer
Sell
435
$170.00
$73.95K
van der Vaart Sandra D
24 Jun 2020
EVP, Chief Legal Officer
Sell
436
$160.33
$69.90K
van der Vaart Sandra D
24 Jun 2020
EVP, Chief Legal Officer
Sell
436
$160.33
$69.90K
KING DAVID P
5 May 2020
Director
Sell
31,250
$160.00
$5.00M
Seltz Judith C
10 Mar 2020
EVP, CHRO
Buy
330
$168.56
$55.62K
Seltz Judith C
28 Feb 2020
EVP, CHRO
Buy
250
$174.94
$43.74K
Wilkinson Peter J
21 Feb 2020
SVP, Chief Accounting Officer
Sell
297
$189.65
$56.33K
BELINGARD JEAN-LUC
19 Feb 2020
Director
Sold after exercise
26,479
$189.76
$5.02M
Williams R Sanders
13 Feb 2020
Director
Sell
1,227
$188.49
$231.28K
Schroeder Mark S
13 Feb 2020
EVP, President-Diagnostics Lab
Sell
103
$188.49
$19.41K
Schroeder Mark S
13 Feb 2020
EVP, President-Diagnostics Lab
Sell
85
$188.49
$16.02K
van der Vaart Sandra D
13 Feb 2020
SVP, Global General Counsel
Sell
103
$188.49
$19.41K
van der Vaart Sandra D
13 Feb 2020
SVP, Global General Counsel
Sell
105
$188.49
$19.79K
van der Vaart Sandra D
10 Feb 2020
SVP, Global General Counsel
Sell
133
$181.99
$24.20K
Schroeder Mark S
10 Feb 2020
EVP, President-Diagnostics Lab
Sell
108
$181.99
$19.65K
KING DAVID P
28 Oct 2019
President & CEO
Sell
12,352
$166.21
$2.05M
KING DAVID P
28 Oct 2019
President & CEO
Sell
10,391
$165.32
$1.72M
KING DAVID P
28 Oct 2019
President & CEO
Sell
7,434
$164.16
$1.22M
ANDERSON KERRII B
23 Sep 2019
Director
Sold after exercise
2,600
$171.85
$446.81K
Uthgenannt Lisa J
4 Sep 2019
Chief Human Resources Officer
Sold after exercise
2,466
$168.59
$415.74K
BERBERIAN LANCE
30 Aug 2019
SVP, Chief Information Officer
Sell
5,902
$169.80
$1.00M
Williams R Sanders
5 Aug 2019
Director
Sell
500
$162.91
$81.46K
van der Vaart Sandra D
8 Jul 2019
SVP, Global General Counsel
Sell
2,328
$176.75
$411.47K
EISENBERG GLENN A
8 Jul 2019
Chief Financial Officer, EVP
Sell
5,563
$176.75
$983.26K
ANDERSON KERRII B
20 Jun 2019
Director
Sold after exercise
3,100
$170.00
$527.00K
EISENBERG GLENN A
7 Jun 2019
Chief Financial Officer, EVP
Sell
1,294
$168.41
$217.92K
EISENBERG GLENN A
7 Jun 2019
Chief Financial Officer, EVP
Sell
4,450
$167.65
$746.05K
EISENBERG GLENN A
7 Jun 2019
Chief Financial Officer, EVP
Sell
4,256
$166.82
$710.00K
Williams R Sanders
6 May 2019
Director
Sell
500
$162.20
$81.10K
MITTELSTAEDT ROBERT E JR
3 May 2019
Director
Sold after exercise
3,700
$166.30
$615.31K
Uthgenannt Lisa J
2 May 2019
Chief Human Resources Officer
Sell
4,000
$164.00
$656.00K
Williams R Sanders
13 Feb 2019
Director
Sell
1,038
$147.00
$152.59K
BELINGARD JEAN-LUC
12 Feb 2019
Director
Sold after exercise
3,700
$146.06
$540.41K
Williams R Sanders
27 Nov 2018
Director
Sell
350
$162.14
$56.75K
ANDERSON KERRII B
5 Nov 2018
Director
Sold after exercise
3,700
$163.29
$604.16K
Dodson Edward T
6 Jun 2018
Principal Accounting Officer
Sold after exercise
13,000
$183.35
$2.38M
Uthgenannt Lisa J
4 Jun 2018
Chief Human Resources Officer
Sell
4,500
$182.10
$819.45K
BERBERIAN LANCE
31 May 2018
SVP, Chief Information Officer
Sell
315
$182.37
$57.45K
BERBERIAN LANCE
31 May 2018
SVP, Chief Information Officer
Sell
5,185
$182.30
$945.23K
Gilliland Dwight Gary
31 May 2018
Director
Sell
400
$181.30
$72.52K
Gilliland Dwight Gary
31 May 2018
Director
Sell
300
$181.29
$54.39K
Gilliland Dwight Gary
31 May 2018
Director
Sell
436
$181.29
$79.04K
Gilliland Dwight Gary
31 May 2018
Director
Sell
127
$181.26
$23.02K
EISENBERG GLENN A
30 May 2018
Chief Financial Officer, EVP
Sell
3,280
$181.50
$595.32K
EISENBERG GLENN A
30 May 2018
Chief Financial Officer, EVP
Sell
6,720
$181.06
$1.22M
Gary M. Huff
30 May 2018
CEO, LabCorp Diagnostics
Sell
1,610
$182.50
$293.82K
KING DAVID P
23 May 2018
President & CEO
Sold after exercise
5,400
$176.13
$951.09K
KING DAVID P
23 May 2018
President & CEO
Sold after exercise
44,566
$175.27
$7.81M
KING DAVID P
23 Apr 2018
President & CEO
Sold after exercise
21,200
$166.37
$3.53M
KING DAVID P
23 Apr 2018
President & CEO
Sold after exercise
28,767
$165.94
$4.77M
KING DAVID P
23 Mar 2018
President & CEO
Sold after exercise
1,700
$166.38
$282.84K
KING DAVID P
23 Mar 2018
President & CEO
Sold after exercise
10,313
$165.39
$1.71M
KING DAVID P
23 Mar 2018
President & CEO
Sold after exercise
36,265
$164.55
$5.97M
KING DAVID P
23 Mar 2018
President & CEO
Sold after exercise
1,689
$163.58
$276.29K
EISENBERG GLENN A
12 Feb 2018
Chief Financial Officer, EVP
Sell
500
$168.61
$84.31K
EISENBERG GLENN A
12 Feb 2018
Chief Financial Officer, EVP
Sell
1,600
$167.78
$268.44K
EISENBERG GLENN A
12 Feb 2018
Chief Financial Officer, EVP
Sell
6,300
$167.16
$1.05M
ANDERSON KERRII B
9 Feb 2018
Director
Sold after exercise
3,300
$166.10
$548.12K
Schechter Adam H
8 Feb 2018
Director
Sell
1,263
$169.29
$213.81K
Gilliland Dwight Gary
30 Oct 2017
Director
Sell
971
$153.52
$149.07K
KING DAVID P
6 Sep 2017
President & CEO
Sold after exercise
7,500
$157.34
$1.18M
KING DAVID P
6 Sep 2017
President & CEO
Sold after exercise
37,187
$156.77
$5.83M
KING DAVID P
5 Sep 2017
President & CEO
Sold after exercise
132,713
$157.06
$20.84M
EBERTS F SAMUEL III
25 Aug 2017
Chief Legal Officer, Secretary
Sold after exercise
31,500
$155.22
$4.89M
Williams R Sanders
11 Aug 2017
Director
Sold after exercise
11
$156.92
$1.73K
Williams R Sanders
11 Aug 2017
Director
Sold after exercise
8
$156.91
$1.26K
Williams R Sanders
11 Aug 2017
Director
Sold after exercise
2,881
$156.90
$452.02K
Williams R Sanders
11 Aug 2017
Director
Sold after exercise
200
$156.68
$31.34K
EISENBERG GLENN A
1 Aug 2017
Chief Financial Officer, EVP
Sell
5,968
$159.46
$951.67K
Uthgenannt Lisa J
1 Aug 2017
Chief Human Resources Officer
Sell
5,000
$160.00
$800.00K
Dodson Edward T
1 Aug 2017
Principal Accounting Officer
Sell
2,671
$160.13
$427.71K
Dodson Edward T
1 Aug 2017
Principal Accounting Officer
Sell
200
$160.13
$32.03K
BERBERIAN LANCE
22 May 2017
SVP, Chief Information Officer
Sell
3,613
$139.84
$505.26K
BELINGARD JEAN-LUC
9 May 2017
Director
Sold after exercise
992
$142.19
$141.05K
EISENBERG GLENN A
9 Mar 2017
Chief Financial Officer, EVP
Sell
2,200
$142.47
$313.44K
EISENBERG GLENN A
9 Mar 2017
Chief Financial Officer, EVP
Sell
100
$142.46
$14.25K
ANDERSON KERRII B
24 Feb 2017
Director
Exercised, kept
1,000
$75.63
$75.63K
MITTELSTAEDT ROBERT E JR
24 Feb 2017
Director
Sold after exercise
367
$142.72
$52.38K
MITTELSTAEDT ROBERT E JR
24 Feb 2017
Director
Sold after exercise
100
$142.70
$14.27K
MITTELSTAEDT ROBERT E JR
24 Feb 2017
Director
Sold after exercise
2,000
$142.69
$285.38K
MITTELSTAEDT ROBERT E JR
24 Feb 2017
Director
Sold after exercise
2,633
$142.69
$375.69K
MITTELSTAEDT ROBERT E JR
24 Feb 2017
Director
Sold after exercise
200
$142.68
$28.54K
ANDERSON KERRII B
23 Feb 2017
Director
Sold after exercise
1,000
$140.00
$140.00K
ANDERSON KERRII B
23 Feb 2017
Director
Sold after exercise
992
$140.00
$138.88K

What was left out

Form 4 filings counted 732
Amendments (4/A) skipped 2
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 35
Sales straight out of an exercise 61
Sales at will 114
Transactions with no price 0
Shares from compensation/vesting 2,552,387
Sales filed before the plan box existed 84
History held since 7 Sep 2016